Brian F. Mandell, MD, PhD
Deputy Editor

Brian F. Mandell, MD, PhD
Deputy Editor

Brian F. Mandell, MD, PhD
Deputy Editor

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: brotmad@ccf.org

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: brotmad@ccf.org

Daniel J. Brotman, MD
Department of General Internal Medicine, The Cleveland Clinic

John P. Girod, DO
Department of General Internal Medicine, The Cleveland Clinic

Address: Daniel J. Brotman, MD, Department of General Internal Medicine, E13, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: brotmad@ccf.org

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sprechd@ccf.org

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sprechd@ccf.org

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Vijay Nambi, MD
Department of Internal Medicine, The Cleveland Clinic

Byron J. Hoogwerf, MD
Director, Internal Medicine Residence Program, Department of Endocrinology, The Cleveland Clinic

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sprechd@ccf.org

Dr. Sprecher has indicated that he has received grant or research support from the Astra/Zeneca/Merck corporation and is also on its speakers’ bureau. He also serves as a consultant for International Medical Innovations, Inc.

This paper discusses treatments that are not approved by the US Food and Drug Administration for some of the uses under discussion.

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

John D. Clough, MD
Editor in Chief

John D. Clough, MD
Editor in Chief

John D. Clough, MD
Editor in Chief

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Daniel J. Mazanec, MD
Director, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Vinod K. Podichetty, MD
Coordinator - Research Studies, Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Augusto Hsia, MD
Spine Center, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic

Address: Daniel J. Mazanec, MD, Spine Center, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mazaned@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Patricia Smith Choban, MD
Bariatric Treatment Center of Ohio, and the Department of Human Nutrition, The Ohio State University, Columbus

Steve Poplawski, MD
Bariatric Treatment Center of Western Michigan

Benita Jackson, MD, MPH
School of Public Health, The Ohio State University, Columbus

Peter Bistolarides, MD
Bariatric Treatment Center of Michigan

Address: Patricia S. Choban, MD, Bariatric Specialists of Ohio, 3989 Jackpot Road, Grove City, OH 43123; e-mail choban.1@osu.edu

Patricia Smith Choban, MD
Bariatric Treatment Center of Ohio, and the Department of Human Nutrition, The Ohio State University, Columbus

Steve Poplawski, MD
Bariatric Treatment Center of Western Michigan

Benita Jackson, MD, MPH
School of Public Health, The Ohio State University, Columbus

Peter Bistolarides, MD
Bariatric Treatment Center of Michigan

Address: Patricia S. Choban, MD, Bariatric Specialists of Ohio, 3989 Jackpot Road, Grove City, OH 43123; e-mail choban.1@osu.edu

Patricia Smith Choban, MD
Bariatric Treatment Center of Ohio, and the Department of Human Nutrition, The Ohio State University, Columbus

Steve Poplawski, MD
Bariatric Treatment Center of Western Michigan

Benita Jackson, MD, MPH
School of Public Health, The Ohio State University, Columbus

Peter Bistolarides, MD
Bariatric Treatment Center of Michigan

Address: Patricia S. Choban, MD, Bariatric Specialists of Ohio, 3989 Jackpot Road, Grove City, OH 43123; e-mail choban.1@osu.edu

Jeff S. Volek, PhD, RD
Assistant Professor, University of Connecticut; Human Performance Laboratory, Department of Kinesiology, University of Connecticut, Storrs

Eric C. Westman, MD, MHS
Associate Professor, Division of General Medicine, Department of Medicine, Duke University Medical Center, Durham, NC

Address: Jeff S. Volek, PhD, RD, Department of Kinesiology, 2095 Hillside Road, Unit 1110, The University of Connecticut, Storrs, CT 06269-1110; e-mail jvolek@uconnvm.uconn.edu

The authors have indicated that they have received grant or research support from the Robert C. Atkins Foundation, Inc.

Jeff S. Volek, PhD, RD
Assistant Professor, University of Connecticut; Human Performance Laboratory, Department of Kinesiology, University of Connecticut, Storrs

Eric C. Westman, MD, MHS
Associate Professor, Division of General Medicine, Department of Medicine, Duke University Medical Center, Durham, NC

Address: Jeff S. Volek, PhD, RD, Department of Kinesiology, 2095 Hillside Road, Unit 1110, The University of Connecticut, Storrs, CT 06269-1110; e-mail jvolek@uconnvm.uconn.edu

The authors have indicated that they have received grant or research support from the Robert C. Atkins Foundation, Inc.

Jeff S. Volek, PhD, RD
Assistant Professor, University of Connecticut; Human Performance Laboratory, Department of Kinesiology, University of Connecticut, Storrs

Eric C. Westman, MD, MHS
Associate Professor, Division of General Medicine, Department of Medicine, Duke University Medical Center, Durham, NC

Address: Jeff S. Volek, PhD, RD, Department of Kinesiology, 2095 Hillside Road, Unit 1110, The University of Connecticut, Storrs, CT 06269-1110; e-mail jvolek@uconnvm.uconn.edu

The authors have indicated that they have received grant or research support from the Robert C. Atkins Foundation, Inc.

George L. Blackburn, MD, PhD
S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215; e-mail gblackbu@caregroup.harvard.edu

Dr. Blackburn has indicated that he has received grant or research support from the Robert C. Atkins Foundation, Inc.

George L. Blackburn, MD, PhD
S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215; e-mail gblackbu@caregroup.harvard.edu

Dr. Blackburn has indicated that he has received grant or research support from the Robert C. Atkins Foundation, Inc.

George L. Blackburn, MD, PhD
S. Daniel Abraham Chair in Nutrition Medicine, Associate Director of Nutrition, Division of Nutrition, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass

Address: George L. Blackburn, MD, PhD, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215; e-mail gblackbu@caregroup.harvard.edu

Dr. Blackburn has indicated that he has received grant or research support from the Robert C. Atkins Foundation, Inc.